Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*Sophie Georgin‐Lavialle, Thomas Cluzeau, Marielle Roux‐Sauvat et al.|British Journal of Dermatology|2021Cited by 414
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas surveyBenjamin Terrier, P. Cacoub, Evguenia Krastinova et al.|Blood|2012Cited by 239
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulationOlivier Kosmider, Benjamin Terrier, Céline Posseme et al.|Nature Communications|2024Cited by 87
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registryBenjamin De Valence, Mikaël Ebbo, M. Delaune et al.|Annals of the Rheumatic Diseases|2023Cited by 70
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A French Nationwide Study of Ninety‐Two PatientsÉtienne Crickx, Irène Machelart, Estibaliz Lazaro et al.|Arthritis & Rheumatology|2015Cited by 69